glp 1 lupus GLP-1 Receptor Agonists Reduce Cardiovascular and Kidney Risks in Patients with Type 2 Diabetes: Study weight-loss-medicines-lupus-ozempic-wegovy-mounjaro-zepbound
Description
Methods Enzymol

In the model of diabetic cardiomyopathy mice, Du et al

Abdul-Ghani MA, Norton L, Defronzo RA

Rather than moving up to higher doses quickly, your PlexusDx provider may recommend remaining at a lower maintenance dose longer, allowing your digestive system to fully adapt

And then I was like, 'Oh, that's actually a good idea
